Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-30 @ 7:42 AM
Study NCT ID:
NCT02104804
Status:
COMPLETED
Last Update Posted:
2017-10-02
First Post:
2014-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05-07
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02-26
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-02
First Submit QC Date:
None
Study First Post Date:
2014-04-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-24
Results First Submit QC Date:
None
Results First Post Date:
2017-10-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-04
Last Update Post Date:
2017-10-02
Last Update Post Date Type:
ACTUAL